Skip to main content

Table 4 Classification of BRCA1-mutated, BRCA1 promoter methylation, and BRCA2-mutated samples

From: BRCAness digitalMLPA profiling predicts benefit of intensified platinum-based chemotherapy in triple-negative and luminal-type breast cancer

 

N with correct classification

BRCA1-like classification

BRCA1-mutated

88% (14/16)

BRCA1 promoter methylation

96% (26/27)

BRCA2-like classification

BRCA2-mutated

93% (13/14)